The cytidine analogue, 5-azacytidine (AZA; 5-AZA-cR), is the primary treatment for myelodysplastic syndrome and chronic myelomonocytic leukaemia. However, only ~50% of treated patients will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback